# Alnylam Pharmaceuticals, Inc.: Form 8-K, filed Apr 30, 2026

- Company: [Alnylam Pharmaceuticals, Inc.](/companies/alny.md) (CIK 1178670)
- Form: 8-K
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 08:04 ET
- Period: 2026-04-30
- Accession: 0001628280-26-028601
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1178670/000162828026028601/alny-20260430.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1178670/000162828026028601/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1178670/000162828026028601/alny-20260430.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-028601. Last ingested by Listed: Oct 31, 2026, 15:25 ET. No prices; not investment advice.